300+ investors in your industry, stage, and region Get
Any industry
EdTech
Venture Capital
Video Games
Hospitality
Restaurants
Crowdfunding
Financial Services
Photography
Cryptocurrency
Digital Media
Big Data
Email
Artificial Intelligence
Clean Energy
Non Profit
Social Impact
Energy
SaaS
Google
CleanTech
Consumer
Health Care
Enterprise Software
Local
Travel
Platforms
InsurTech
Construction
Mobile
Oil and Gas
Film
Retail
Payments
Marketplace
Fitness
Organic Food
Machine Learning
Agriculture (AgTech)
Gaming
B2B
Social Network
Medical Device
Wellness
Education
Sports
Legal
Automotive
eSports
Biotechnology
Renewable Energy
Facebook
Blockchain
Software
Theatre
Medical
Web3
Recruiting
Beauty
Celebrity
Cannabis
Fashion
LGBT
Climate
Infrastructure
Food and Beverage
Life Science
Publishing
Wine and Spirits
Mobile Apps
Real Estate
Sporting Goods
Music
Social
Art
Finance
Manufacturing
FinTech
Social Media
Franchise
Internet
Mobile Advertising
Android
Impact
Proptech
Hardware
Transportation
Biotech
Sustainability
Enterprise
Community
Media (Entertainment)
Any country
Afghanistan
Greece
Thailand
United Arab Emirates
Andorra
Dominica
Japan
Brazil
Singapore
Burkina Faso
Africa
LATAM
Egypt
United Kingdom
Oceania
Argentina
Faroe Islands
South Korea
Hong Kong
Benin
Nigeria
Togo
Croatia
Gibraltar
Guinea
Kyrgyzstan
Norway
Haiti
Sudan
Malawi
Isle of Man
Iran
Madagascar
Lesotho
Russian Federation
Turkey
Liberia
Nepal
Pakistan
Mexico
Tajikistan
Sweden
Zambia
Romania
Tunisia
Taiwan
Oman
Zimbabwe
Poland
Puerto Rico
Guernsey
Cameroon
Colombia
Armenia
China
Costa Rica
Côte d'Ivoire
Czech Republic
Marshall Islands
Kuwait
Luxembourg
Malta
Mozambique
Namibia
Mauritius
Nicaragua
Panama
Serbia
Uzbekistan
Morocco
Australia
Jamaica
Sri Lanka
Guatemala
Switzerland
Kazakhstan
Cayman Islands
Venezuela
Myanmar
Uganda
Uruguay
New Zealand
Moldova
Seychelles
Botswana
Paraguay
South Africa
France
Denmark
Georgia
Ghana
Iraq
Philippines
Portugal
Sierra Leone
El Salvador
Senegal
India
Germany
Canada
Ireland
Saudi Arabia
Latvia
Kenya
Mali
Malaysia
Rwanda
Tanzania
United States
Indonesia
Middle East
Dominican Republic
Bermuda
Asia
Albania
Spain
Angola
Europe
Cyprus
Qatar
Bangladesh
Barbados
Belgium
Austria
Ethiopia
Jordan
Azerbaijan
Ecuador
Bulgaria
Bahamas
Bahrain
Jersey
Estonia
Bolivia
Belize
Algeria
Belarus
Finland
Italy
Hungary
Grenada
Israel
Honduras
Lithuania
Liechtenstein
Cambodia
Iceland
Lebanon
Mongolia
Peru
Slovenia
San Marino
Ukraine
Vietnam
Chile
Angel Investors
VC Funds
All Investors
Access Full Database - Free Forever
Open database

Yipu Capital

VC Fund

Yipu Capital is an investment firm

Total investments:
9
Last investment:
Lead investor:
0%

Last updated:

Industries Yipu Capital invests in

BiotechnologyBiopharmaHealth CareManufacturingSemiconductor

Stages Yipu Capital invests in

Series BSeedAngelSeries ASeries C

Countries Yipu Capital invests in

China

Investment Focus

Industry

  • Biotechnology 4 (44%)
  • Biopharma 2 (22%)
  • Health Care 2 (22%)
  • Manufacturing 2 (22%)
  • Semiconductor 2 (22%)
See all 14 industries →

Stage

  • Series B 4 (44%)
  • Seed 1 (11%)
  • Angel 1 (11%)
  • Series A 1 (11%)
  • Series C 1 (11%)
See all 6 stages →

Investments

CompanyDescriptionRoundLinks
Lawnics Technology
Lawonics is a manufacturer specializing in high-end intelligent garden and power tools. The company focuses on research, development, and production of garden tools and intelligent equipment, providing smart solutions for various garden and life scenarios. It continuously improves product performance and user experience through advancedtechnologies like intelligent drive, precise calibration, and automatic charging. Venture - Series Unknown / Apr 21, 2026
Ronovo Surgical Ronovo Surgical
Ronovo Surgical is an emerging medtech company focused on innovating minimally invasive (MIS) and digital surgery. $28.3M / Series B / Aug 30, 2023
Bio-Engine Bio-Engine
Bio-Engine is a developer of high-density serum-free suspension culture technology for animal cells. Its main products include HEK293 cell serum-free medium, PK15 cell serum-free medium, etc., which can be applied to antibodies, recombinant proteins, human and livestock. Virus vaccine, cell therapy and other fields. $43.1M / Series C / May 15, 2023
Qixin Micro Semiconductor Qixin Micro Semiconductor
Suzhou Qixin Micro Semiconductor Co., Ltd. was established in October 2020. Based on the ARM Cortex M4, M7 and other series of architectures, it will build high-performance and high-reliability system-on-chips for different automotive application scenarios, and develop high-end smart car controller chips. Through the use of self-developed IP,unique multi-core lock-step technologies, and the unique Six Sigma analog circuit design process for automotive-standard chips, a full series of product families covering safety standards ISO26262 ASIL-B to ASIL-D have been designed. The company's products all meet the automotive regulations AEC-Q100, functional safety standard ISO26262 and various automotive regulations reliability tests, and can be widely used in the fields of body, automotive instrumentation, safety, power, battery management and other fields. The company is mainly engaged in the research and development and sales of high-end automotive controller chips. The goal is to fill the gap in the domestic new generation of intelligent networked automotive controller chips, and is committed to becoming a leading manufacturer in the field of automotive and industrial controllers in China. Series B / Jul 07, 2022
EVAS Intelligence EVAS Intelligence
EVAS Intelligence is an autonomous driving chip startup. The company was founded by Liu Hui. $28.3M / Seed / Mar 01, 2022
EVAS Intelligence EVAS Intelligence
EVAS Intelligence is an autonomous driving chip startup. The company was founded by Liu Hui. $31.7M / Angel / Mar 01, 2022
LakeShore Biopharma LakeShore Biopharma
Yisheng Biopharma is a global, fully integrated biopharmaceutical company engaged in discovering, developing and commercializing innovative biotherapeutics for cancers and infectious diseases using our novel PIKA® immunomodulating technology. PIKA technology augments both innate and adaptive immune responses through the TLR3, RIG-I and MDA5pathways. Products in clinical development include YS-ON-001 for the treatment of advanced solid tumors, YS-HBV-001 hepatitis B vaccine and the PIKA rabies vaccine for accelerated protection against rabies infection. $130M / Series B / Feb 24, 2021
Lepu Bio Lepu Bio
Lepu Bio is a biotech company that develops a tumor immunology technology. It has established an industrial platform for target discovery, drug discovery, development, and production. The company's core products, PD-1, PD-L1, oncolytic virus, and multiple ADC products, have entered the clinical stage I-III. Series A / Apr 01, 2020
Transcenta Transcenta
Transcenta is a global biotherapeutic company that fully integrates antibody-based biotherapeutics discovery, R&D and manufacture, focusing on developing innovative antibodies to help more patients. HJB and MabSpace Biosciences merged and created Transcenta. $100M / Series B / Jan 08, 2020

Co-Investors

Access 48,091 investors

822 industries, 177 countries. Updated daily. Emails and phones included.

Browse database — It's Free!

Find investors for your startup

Search 48,091 investors by industry and country. Emails and phones included.

Any industry
EdTech
Venture Capital
Video Games
Hospitality
Restaurants
Crowdfunding
Financial Services
Photography
Cryptocurrency
Digital Media
Big Data
Email
Artificial Intelligence
Clean Energy
Non Profit
Social Impact
Energy
SaaS
Google
CleanTech
Consumer
Health Care
Enterprise Software
Local
Travel
Platforms
InsurTech
Construction
Mobile
Oil and Gas
Film
Retail
Payments
Marketplace
Fitness
Organic Food
Machine Learning
Agriculture (AgTech)
Gaming
B2B
Social Network
Medical Device
Wellness
Education
Sports
Legal
Automotive
eSports
Biotechnology
Renewable Energy
Facebook
Blockchain
Software
Theatre
Medical
Web3
Recruiting
Beauty
Celebrity
Cannabis
Fashion
LGBT
Climate
Infrastructure
Food and Beverage
Life Science
Publishing
Wine and Spirits
Mobile Apps
Real Estate
Sporting Goods
Music
Social
Art
Finance
Manufacturing
FinTech
Social Media
Franchise
Internet
Mobile Advertising
Android
Impact
Proptech
Hardware
Transportation
Biotech
Sustainability
Enterprise
Community
Media (Entertainment)
Any country
Afghanistan
Greece
Thailand
United Arab Emirates
Andorra
Dominica
Japan
Brazil
Singapore
Burkina Faso
Africa
LATAM
Egypt
United Kingdom
Oceania
Argentina
Faroe Islands
South Korea
Hong Kong
Benin
Nigeria
Togo
Croatia
Gibraltar
Guinea
Kyrgyzstan
Norway
Haiti
Sudan
Malawi
Isle of Man
Iran
Madagascar
Lesotho
Russian Federation
Turkey
Liberia
Nepal
Pakistan
Mexico
Tajikistan
Sweden
Zambia
Romania
Tunisia
Taiwan
Oman
Zimbabwe
Poland
Puerto Rico
Guernsey
Cameroon
Colombia
Armenia
China
Costa Rica
Côte d'Ivoire
Czech Republic
Marshall Islands
Kuwait
Luxembourg
Malta
Mozambique
Namibia
Mauritius
Nicaragua
Panama
Serbia
Uzbekistan
Morocco
Australia
Jamaica
Sri Lanka
Guatemala
Switzerland
Kazakhstan
Cayman Islands
Venezuela
Myanmar
Uganda
Uruguay
New Zealand
Moldova
Seychelles
Botswana
Paraguay
South Africa
France
Denmark
Georgia
Ghana
Iraq
Philippines
Portugal
Sierra Leone
El Salvador
Senegal
India
Germany
Canada
Ireland
Saudi Arabia
Latvia
Kenya
Mali
Malaysia
Rwanda
Tanzania
United States
Indonesia
Middle East
Dominican Republic
Bermuda
Asia
Albania
Spain
Angola
Europe
Cyprus
Qatar
Bangladesh
Barbados
Belgium
Austria
Ethiopia
Jordan
Azerbaijan
Ecuador
Bulgaria
Bahamas
Bahrain
Jersey
Estonia
Bolivia
Belize
Algeria
Belarus
Finland
Italy
Hungary
Grenada
Israel
Honduras
Lithuania
Liechtenstein
Cambodia
Iceland
Lebanon
Mongolia
Peru
Slovenia
San Marino
Ukraine
Vietnam
Chile
Angel Investors
VC Funds
All Investors

Similar Investors

Recommended lists

FAQ

What does Yipu Capital invest in?

Yipu Capital invests primarily in Biotechnology, Biopharma and Health Care startups, most often at Series B and Seed stage. Most of the 9 investments tracked by Shizune back companies in China. The Investment Focus section breaks down every industry, stage and country in the portfolio.

When did Yipu Capital last invest?

The most recent investment recorded for Yipu Capital closed in Apr 2026. Shizune tracks 9 investments in total for this profile, including round sizes, stages and portfolio companies, all sourced from confirmed public funding rounds and refreshed monthly.

Is Shizune's investor data accurate?

Yes — every stat on this profile is calculated from confirmed public funding rounds monitored across hundreds of sources since 2020. This profile was last refreshed in Aug 2026 and is updated monthly. Spotted something off? Use the “Suggest an edit” link near the top of the page.

Contact your first 100 investors today

Find who invests in your industry, stage, and country. Download investor list with emails in 5 minutes.

Find investors — It's Free!
Yipu Capital Find emails